Stoke Therapeutics, Inc. logo

Stoke Therapeutics, Inc.

STOK • NASDAQ • Stock Fundamentals

Stoke Therapeutics, Inc. is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Ian F. Smith, with a market cap of $1.8B.

Market Cap$1.8B
Employees110.0
CEOIan F. Smith
CountryUnited States of America
Healthcare
Biotechnology
Most Recent EarningsMay 7, 2026 · 19 days agoQ1 2026
View report
Next EarningsAug 11, 2026 · in 3 monthsQ2 2026
Income StatementBalance SheetCash FlowSegments

Financials

Based on Q1 2026 filing

View all metrics
Stoke Therapeutics, Inc. logo

Stoke Therapeutics, Inc. FAQ

Common questions about Stoke Therapeutics, Inc.

Stoke Therapeutics, Inc. (STOK) has a market capitalization of $1.8B and trades on NASDAQ.

Stoke Therapeutics, Inc. has approximately 110 employees.